| Prevalence of depression in cancer patients: a meta‐analysis of diagnostic interviews and self‐report instruments AMH Krebber, LM Buffart, G Kleijn, IC Riepma, R De Bree, CR Leemans, ... Psycho‐Oncology 23 (2), 121-130, 2014 | 1003 | 2014 |
| COVID‐19 pandemic: effects and evidence‐based recommendations for otolaryngology and head and neck surgery practice LP Kowalski, A Sanabria, JA Ridge, WT Ng, R de Bree, A Rinaldo, ... Head & neck 42 (6), 1259-1267, 2020 | 380 | 2020 |
| Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer C Schilling, SJ Stoeckli, SK Haerle, MA Broglie, GF Huber, JA Sorensen, ... European journal of cancer 51 (18), 2777-2784, 2015 | 378 | 2015 |
| Screening for distant metastases in patients with head and neck cancer R de Bree, EE Deurloo, GB Snow, CR Leemans The Laryngoscope 110 (3), 397-401, 2000 | 372 | 2000 |
| A phase I dose escalation study with anti-CD44v6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus BM Tijink, J Buter, R De Bree, G Giaccone, MS Lang, A Staab, ... Clinical Cancer Research 12 (20), 6064-6072, 2006 | 348 | 2006 |
| Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial GO Janssens, SE Rademakers, CH Terhaard, PA Doornaert, HP Bijl, ... Journal of clinical oncology 30 (15), 1777-1783, 2012 | 302 | 2012 |
| Staging and grading of oral squamous cell carcinoma: An update A Almangush, AA Mäkitie, A Triantafyllou, R de Bree, P Strojan, A Rinaldo, ... Oral oncology 107, 104799, 2020 | 275 | 2020 |
| Oral mucosal organoids as a potential platform for personalized cancer therapy E Driehuis, S Kolders, S Spelier, K Lõhmussaar, SM Willems, LA Devriese, ... Cancer discovery 9 (7), 852-871, 2019 | 275 | 2019 |
| Performance of immuno–positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer … PKE Börjesson, YWS Jauw, R Boellaard, R De Bree, EFI Comans, ... Clinical Cancer Research 12 (7), 2133-2140, 2006 | 271 | 2006 |
| Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study JC Glasbey, D Nepogodiev, JFF Simoes, O Omar, E Li, ML Venn, PGDME, ... Journal of Clinical Oncology 39 (1), 66-78, 2021 | 266 | 2021 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 248 | 2021 |
| Early diagnosis in primary oral cancer: is it possible? I Van der Waal, R de Bree, R Brakenhoff, JW Coebegh Medicina oral, patologia oral y cirugia bucal 16 (3), e300-e305, 2011 | 242 | 2011 |
| Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients JE Swartz, AJ Pothen, I Wegner, EJ Smid, KMA Swart, R de Bree, ... Oral oncology 62, 28-33, 2016 | 237 | 2016 |
| Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma LWT Alkureishi, Z Burak, JA Alvarez, J Ballinger, A Bilde, AJ Britten, ... European journal of nuclear medicine and molecular imaging 36, 1915-1936, 2009 | 223 | 2009 |
| Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities G Regelink, J Brouwer, R De Bree, J Pruim, BF Van Der Laan, ... European journal of nuclear medicine and molecular imaging 29, 1024-1030, 2002 | 222 | 2002 |
| Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer AW Wendrich, JE Swartz, SI Bril, I Wegner, A de Graeff, EJ Smid, ... Oral oncology 71, 26-33, 2017 | 216 | 2017 |
| Distress in spouses and patients after treatment for head and neck cancer IM Verdonck‐de Leeuw, SE Eerenstein, MH Van der Linden, DJ Kuik, ... The Laryngoscope 117 (2), 238-241, 2007 | 213 | 2007 |
| Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects RP Takes, A Rinaldo, CE Silver, M Haigentz Jr, JA Woolgar, ... Oral oncology 48 (9), 775-779, 2012 | 210 | 2012 |
| Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches P Strojan, A Ferlito, JE Medina, JA Woolgar, A Rinaldo, KT Robbins, ... Head & neck 35 (1), 123-132, 2013 | 207 | 2013 |
| Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients PKE Börjesson, YWS Jauw, R de Bree, JC Roos, JA Castelijns, ... Journal of Nuclear Medicine 50 (11), 1828-1836, 2009 | 207 | 2009 |
